Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation

Class:IdLiteratureReference:9761694
_displayNamec-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
_timestamp2022-01-15 22:48:17
author[Person:9761684] Tang, Ya-Chu
[Person:9761686] Hsiao, Jenn-Ren
[Person:9761685] Jiang, Shih-Sheng
[Person:2399824] Chang, Jang-Yang
[Person:5623753] Chu, Pei-Yi
[Person:9761690] Liu, Ko-Jiunn
[Person:9761687] Fang, Hsun-Lang
[Person:9761696] Lin, Li-Mei
[Person:9761697] Chen, Huang-Hui
[Person:9761688] Huang, Yen-Wen
[Person:9761691] Chen, Yu-Tsen
[Person:9761692] Tsai, Fang-Yu
[Person:8852968] Lin, Su-Fang
[Person:9761695] Chuang, Yung-Jen
[Person:9761693] Kuo, Ching-Chuan
created[InstanceEdit:9761689] Rothfels, Karen, 2022-01-15
journalTheranostics
pages5232-5247
pubMedIdentifier33859744
titlec-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
volume11
year2021
(literatureReference)[BlackBoxEvent:8932309] NFE2L2 translocates from cytosol to nucleoplasm [Homo sapiens]
[Reaction:9761812] AcK- NFE2L2, MAFG and CREBBP, EP300 bind the G6PD [Homo sapiens]
[Reaction:9761834] NFE2L2 binds the TKT gene [Homo sapiens]
[BlackBoxEvent:9761852] NFE2L2-dependent TKT gene expression [Homo sapiens]
[Reaction:9762097] MYC binds the NFE2L2 promoter [Homo sapiens]
[BlackBoxEvent:9762100] MYC- and NICD1-dependent NFE2L2 gene expression [Homo sapiens]
[Complex:9761735] TKT gene:p-NFE2L2 [nucleoplasm] [Homo sapiens]
[RegulationReference:9761861] Positive gene expression regulation by 'TKT gene:p-NFE2L2 [nucleoplasm]' c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
[RegulationReference:9762101] Positive gene expression regulation by 'NFE2L2 gene:MYC [nucleoplasm]' c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
[Change default viewing format]
No pathways have been reviewed or authored by c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation (9761694)